Meet Explicyte! Join us at The 37th annual SITC event in Boston

We very much look forward to attending the @Society for Immunotherapy of Cancer Annual Meeting in Boston from November 8 to 12, and to showcasing our recent research works through our posters. Plan to stop by to talk of them and about your research programs.

Interested in meeting us to learn on our services offerings and how they can support your needs? Reach us for scheduling!

We very much look forward to attending the Society for Immunotherapy of Cancer Annual Meeting in Boston, and to showcasing our recent research works through the three posters below. Plan to stop by to talk of them and about your research programs.
Interested in meeting us to learn on our services offerings and how they can support your needs? Reach out to Alban Bessede for scheduling.

Identification of super-exhausted T cells: a novel population predictive of response to immunotherapy Abstract #135, by Alban Bessede Biomarkers, Immune Monitoring and Novel Technologies November 10, Poster Hall, Hall C

Indoleamine 2,3 dioxygenase expression predicts response to Immune Checkpoint Blockers in advanced Non-Small Cell Lung Cancer Abstract #141, by Alban Bessede Biomarkers, Immune Monitoring and Novel Technologies November 10, Poster Hall, Hall C

Comprehensive analysis of a novel anti-PD1 resistant sarcoma mouse model Abstract #1426, by Alban Bessede Tumor and Stromal Cell Biology November 11, Poster Hall, Hall C

 

Schedule an in-person meeting with us!